biological collection: * Tissue samples (tumor tissue and healthy tissue) frozen and secured in paraffin collected during surgery.
* Blood samples taken at different times. During the blood samples taken for diagnosis and / or treatment, additional samples for research purposes will be carried out.
Study summary
The BCB is a tool:
* for research in analytical and public health epidemiology, biological research and for the development of data useful for clinical research and therapeutic trials;
* to help scientists understand and explain phenomena ranging from the interaction of molecules to the whole metabolism of the organism in normal and pathological situations;
* to identify potential strategies for prevention, diagnosis, management and analysis of cancer subtypes.
The creation of a broad clinical and biological prospective base dedicated to different types of cancer is essential for the development of such projects.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age\> at 18 years old,
* Patient with invasive or in situ tumor pathology (proven or suspected) any stage confounded,
* Patient in ICM at diagnosis
* a digestive cancer (esophagus, stomach, pancreas, colon, rectum, anal canal) or
* gynecological cancer (ovary, endometrium, cervix) or
* breast cancer or
* sarcoma.
* Naïve patient of any treatment for the present cancer,
* Patient requiring treatment involving at least one (or more) tumor surgery (s)
* Patient who has accepted supplementary blood samples,
* Patient having given his informed, written and express consent.
Exclusion Criteria:
* Patient not affiliated to a social protection scheme,
* Patient whose regular follow-up is a priori impossible for psychological, familial, social or geographical reasons,
* Pregnant and / or nursing women,
* Subject under tutelage, curatorship or safeguard of justice,
* Patient in an emergency situation.
Primary outcome measure(s)
Proportion of patients who consent to participate in the study — through study completion, an average of 1 year the proportion of patients who consent to participate in the study among the screened patients
Trial sites (1)
Facility
City
Region
Status
Institut regional du Cancer - Val d Aurelle
Montpellier
France
Recruiting
More Institut du Cancer de Montpellier - Val d'Aurelle trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
